Survival after stereotactic radiotherapy in patients with early-stage non-small cell lung cancer

References

• Guckenberger M, Andratschke N, Dieckmann K, et al. ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. Radiother Oncol. 2017;124:11–17.
   PubMed Web of Science ®Google Scholar
• Nyman J, Hallqvist A, Lund JA, et al. SPACE – a randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiother Oncol. 2016;121:1–8.
   PubMed Web of Science ®Google Scholar
• Ball D, Mai GT, Vinod S, et al. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncol. 2019;20:494–503.
   Web of Science ®Google Scholar
• Kristiansen C, Schytte T, Hansen KH, et al. Trends in lung cancer in elderly in Denmark, 1980–2012. Acta Oncol. 2016;55 Suppl. 1:46–51.
   PubMed Web of Science ®Google Scholar
• Jeppesen SS, Hansen NCG, Schytte T, et al. Survival of localized NSCLC patients without active treatment or treated with SBRT. Acta Oncol. 2018;57:219–225.
   PubMed Web of Science ®Google Scholar
• Mihai A, Milano MT, Santos A, et al. Treatment completion, treatment compliance and outcomes of old and very old patients treated by dose adapted stereotactic ablative radiotherapy (SABR) for T1-T3N0M0 non-small cell lung cancer. J Geriatr Oncol. 2019;10:442–448.
   PubMed Web of Science ®Google Scholar
• Shinde A, Li R, Kim J, et al. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly. Semin Oncol. 2018;45:210–219.
   PubMed Web of Science ®Google Scholar
• Jorgensen TL, Hallas J, Friis S, et al. Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer. 2012;106:1353–1360.
   PubMed Web of Science ®Google Scholar
• Jeppesen SS, Schytte T, Jensen HR, et al. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates. Acta Oncol. 2013;52:1552–1558.
   PubMed Web of Science ®Google Scholar
• Cassidy RJ, Patel PR, Zhang X, et al. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer in patients 80 years and older: a multi-center analysis. Clin Lung Cancer. 2017;18:551–558.
   PubMed Web of Science ®Google Scholar
• Kreinbrink P, Blumenfeld P, Tolekidis G, et al. Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (≥80 years old): extremely safe and effective. J Geriatr Oncol. 2017;8:351–355.
   PubMed Web of Science ®Google Scholar
• Sandhu AP, Lau SK, Rahn D, et al. Stereotactic body radiation therapy in octogenarians with stage I lung cancer. Clin Lung Cancer. 2014;15:131–135.
   PubMed Web of Science ®Google Scholar
• Takeda A, Sanuki N, Eriguchi T, et al. Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013;86:257–263.
   PubMed Web of Science ®Google Scholar
• van der Voort van Zyp N, van der Holt B, Van Klaveren RJ, et al. Stereotactic body radiotherapy using real-time tumor tracking in octogenarians with non-small cell lung cancer. Lung Cancer. 2010;69:296–301.
   PubMed Web of Science ®Google Scholar
• Mellemgaard A, Lüchtenborg M, Iachina M, et al. Role of comorbidity on survival after radiotherapy and chemotherapy for nonsurgically treated lung cancer. J Thorac Oncol. 2015;10:272–279.
   PubMed Web of Science ®Google Scholar
• Klement RJ, Belderbos J, Grills I, et al. Prediction of early death in patients with early-stage NSCLC—can we select patients without a potential benefit of SBRT as a curative treatment approach? J Thorac Oncol. 2016;11:1132–1139.
   PubMed Web of Science ®Google Scholar
• Maebayashi T, Ishibashi N, Aizawa T, et al. Significance of stereotactic body radiotherapy in older patients with early stage non-small cell lung cancer. J Geriatr Oncol. 2018;9:594–599.
   PubMed Web of Science ®Google Scholar
• Jeppesen SS, Matzen LE, Brink C, et al. Impact of comprehensive geriatric assessment on quality of life, overall survival, and unplanned admission in patients with non-small cell lung cancer treated with stereotactic body radiotherapy. J Geriatr Oncol. 2018;9:575–582.
   PubMed Web of Science ®Google Scholar
• Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833–4839.
   PubMed Web of Science ®Google Scholar